Skip to main content

Advertisement

SpringerLink
Log in

Peripheral Ulcerative Keratitis: Management

  • Cornea (K Houser, Section Editor)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This study aimed to discuss an updated, evidence-supported, stepwise approach to the diagnosis and treatment of peripheral ulcerative keratitis (PUK).

Recent Findings

PUK conventionally describes a rapidly progressive, crescent-shaped, peripheral, and inflammatory corneal melt. Undertreated PUK may lead to vision loss and premature mortality. A comprehensive approach includes diagnosis, short-term treatment, long-term treatment, and surgical considerations. Diagnosis is based on clinical findings. Next, the clinician should pursue an underlying etiology with a meticulous workup, including careful consideration of microbial keratitis. Common causes are rheumatoid arthritis, microbial keratitis, systemic necrotizing vasculitis (such as granulomatosis with polyangiitis), and collagen vascular disease (such as systemic lupus erythematosus). For short-term management of noninfectious PUK, therapy involves intensive anti-inflammatory therapy with corticosteroids. Adjunctive therapies such as conjunctival resection, amnionic membrane transplantation, and topical cyclosporine are also discussed. Recurrence commonly occurs, sometimes months to years later. Recurrence is a major source of premature vision loss. Additionally, smoldering disease activity seems to confer a risk of early mortality. Therefore, we recommend starting or escalating immunomodulatory therapy patients in most patients with sight-threatening, steroid-responsive, noninfectious PUK, especially (but not limited to) those with systemic features or a corneal graft.

Summary

PUK is a sight-threatening condition that requires a short-term and long-term view of the disease. Multidisciplinary collaboration with other physicians is crucial to achieve optimal outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gupta Y, Kishore A, Kumari P, Balakrishnan N, Lomi N, Gupta N, Vanathi M, Tandon R. Peripheral ulcerative keratitis. Surv Ophthalmol. 2021;66:977–98.

    Article  Google Scholar 

  2. Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33:835–54 (vii).

    Article  Google Scholar 

  3. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000;19:625–43.

    Article  CAS  Google Scholar 

  4. Watson PG. Anterior segment fluorescein angiography in the surgery of immunologically induced corneal and scleral destructive disorders. Ophthalmology. 1987;94:1452–64.

    Article  CAS  Google Scholar 

  5. Watson PG. Vascular changes in peripheral corneal destructive disease. Eye (Lond). 1990;4(Pt 1):65–73.

    Article  Google Scholar 

  6. Kervick GN, Pflugfelder SC, Haimovici R, Brown H, Tozman E, Yee R. Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. Ophthalmology. 1992;99:80–8.

    Article  CAS  Google Scholar 

  7. Tauber J. Sainz de la Maza M, Hoang-Xuan T, Foster CS: An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9:66–73.

    Article  CAS  Google Scholar 

  8. Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol. 2002;120:15–9.

    Article  Google Scholar 

  9. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43:379–96.

    Article  CAS  Google Scholar 

  10. Knox Cartwright NE, Tole DM, Georgoudis P, Cook SD. Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison. Cornea. 2014;33:27–31.

    Article  Google Scholar 

  11. Malik R, Culinane AB, Tole DM, Cook SD. Rheumatoid keratolysis: a series of 40 eyes. Eur J Ophthalmol. 2006;16:791–7.

    Article  CAS  Google Scholar 

  12. Timlin HM, Hall HN, Foot B, Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit. Br J Ophthalmol. 2018;102:1298–302.

    Article  Google Scholar 

  13. McKibbin M, Isaacs JD, Morrell AJ. Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995–7. Br J Ophthalmol. 1999;83:941–3.

    Article  CAS  Google Scholar 

  14. Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis ‘corneal melt’ and rheumatoid arthritis: a case series. Rheumatology (Oxford). 1999;38:1245–8.

    Article  CAS  Google Scholar 

  15. Fasina O, Ogundipe A, Ezichi E. Mooren’S ulcer in ibadan, southwest Nigeria. J West Afr Coll Surg. 2013;3:102–19.

    CAS  Google Scholar 

  16. Sharma N, Sinha G, Shekhar H, Titiyal JS, Agarwal T, Chawla B, Tandon R, Vajpayee RB. Demographic profile, clinical features and outcome of peripheral ulcerative keratitis: a prospective study. Br J Ophthalmol. 2015;99:1503–8.

    Article  Google Scholar 

  17. Srinivasan M, Zegans ME, Zelefsky JR, Kundu A, Lietman T, Whitcher JP, Cunningham ET Jr. Clinical characteristics of Mooren’s ulcer in South India. Br J Ophthalmol. 2007;91:570–5.

    Article  Google Scholar 

  18. Asbell P, Stenson S. Ulcerative keratitis. Survey of 30 years’ laboratory experience. Arch Ophthalmol. 1982;100:77–80.

    Article  CAS  Google Scholar 

  19. Baum J, Fedukowicz HB, Jordan A. A survey of Moraxella corneal ulcers in a derelict population. Am J Ophthalmol. 1980;90:476–80.

    Article  CAS  Google Scholar 

  20. O’Donoghue E, Lightman S, Tuft S, Watson P. Surgically induced necrotising sclerokeratitis (SINS)—precipitating factors and response to treatment. Br J Ophthalmol. 1992;76:17–21.

    Article  CAS  Google Scholar 

  21. Diaz-Valle D. Benitez del Castillo JM, Castillo A, Sayagues O, Banares A, Garcia-Sanchez J: Immunologic and clinical evaluation of postsurgical necrotizing sclerocorneal ulceration. Cornea. 1998;17:371–5.

    Article  CAS  Google Scholar 

  22. Akpek EK, Demetriades AM, Gottsch JD. Peripheral ulcerative keratitis after clear corneal cataract extraction(1). J Cataract Refract Surg. 2000;26:1424–7.

    Article  CAS  Google Scholar 

  23. Kiire CA, Srinivasan S, Inglis A. Peripheral ulcerative keratitis after cataract surgery in a patient with ocular cicatricial pemphigoid. Cornea. 2011;30:1176–8.

    Article  Google Scholar 

  24. Burkholder BM, Kuo IC. Peripheral ulcerative keratitis following laser in situ keratomileusis. Case Rep Ophthalmol. 2016;7:9–15.

    Article  Google Scholar 

  25. Pokharel A, Subedi S, Bajracharya M. Peripheral ulcerative keratitis triggered by bacterial conjunctivitis. Nepal J Ophthalmol. 2010;2:71–3.

    Article  CAS  Google Scholar 

  26. Zaher SS, Sandinha T, Roberts F, Ramaesh K. Herpes simplex keratitis misdiagnosed as rheumatoid arthritis-related peripheral ulcerative keratitis. Cornea. 2005;24:1015–7.

    Article  Google Scholar 

  27. Praidou A, Androudi S, Kanonidou E, Konidaris V, Alexandridis A, Brazitikos P. Bilateral herpes simplex keratitis presenting as peripheral ulcerative keratitis. Cornea. 2012;31:570–1.

    Article  Google Scholar 

  28. Chranioti A, Malamas A, Metallidis S, Mataftsi A, Chalvatzis N, Ziakas N. Bilateral Herpes Simplex virus-related peripheral ulcerative keratitis leading to corneal perforation in a patient with primary Herpes Simplex virus infection. J Ophthalmic Vis Res. 2019;14:93–6.

    Article  Google Scholar 

  29. Neves RA, Rodriguez A, Power WJ, Muccioli C, Lane L, Belfort R Jr, Foster CS. Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome. Cornea. 1996;15:446–50.

    Article  CAS  Google Scholar 

  30. Gupta N, Sachdev R, Sinha R, Titiyal JS, Tandon R. Herpes zoster ophthalmicus: disease spectrum in young adults. Middle East Afr J Ophthalmol. 2011;18:178–82.

    Article  Google Scholar 

  31. Vignesh AP, Srinivasan R, Vijitha S. Ocular syphilis masquerading as bilateral peripheral ulcerative keratitis. Taiwan J Ophthalmol. 2016;6:204–5.

    Article  CAS  Google Scholar 

  32. Gharai S, Venkatesh P, Tandon R, Garg S. Peripheral ulcerative keratitis and central retinal vein occlusion as the initial manifestation of HIV infection. Ocul Immunol Inflamm. 2007;15:407–9.

    Article  Google Scholar 

  33. Soni ND, Ingole AB, Murade SM. An unusual case of peripheral ulcerative keratitis as a presenting feature in an otherwise healthy patient with undiagnosed human immunodeficiency virus infection and low CD4 counts. Indian J Ophthalmol. 2013;61:138–9.

    Article  Google Scholar 

  34. Tavassoli S, Gunn D, Tole D, Darcy K. Peripheral ulcerative keratitis with corneal melt as the primary presentation in a case of human immunodeficiency virus. BMJ Case Rep. 2019;12.

  35. Radhakrishnan N, Smit D, Venkatesh Prajna N. S RR: Corneal involvement in HIV-infected individuals. Ocul Immunol Inflamm. 2021;29:1177–82.

    Article  CAS  Google Scholar 

  36. Jiamjunkupt T, Sasiprapha N, Changpradub D, Choontanom R, Sansanayudh W. Rare manifestation of ocular immune reconstitution inflammatory syndrome from mycobacterium scrofulaceum infection in a patient with AIDS. Int J Mycobacteriol. 2021;10:202–5.

    Google Scholar 

  37. Pluznik D, Butrus SI. Hepatitis C-associated peripheral corneal ulceration: rapid response to intravenous steroids. Cornea. 2001;20:888–9.

    Article  CAS  Google Scholar 

  38. Wenkel H, Krist D, Korn K. Detection of hepatitis C virus RNA in tear film of a patient with recurrent peripheral corneal ulcers. Klin Monbl Augenheilkd. 2001;218:459–62.

    Article  CAS  Google Scholar 

  39. Kedhar SR, Belair ML, Jun AS, Sulkowski M, Thorne JE. Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia. Arch Ophthalmol. 2007;125:852–3.

    Article  Google Scholar 

  40. Eshraghi H, Mahtabfar A, Dastjerdi MH. A case of peripheral ulcerative keratitis associated with autoimmune hepatitis. Case Rep Med. 2017;2017:3939413.

    Article  Google Scholar 

  41. Wei DW, Pagnoux C, Chan CC. Peripheral ulcerative keratitis secondary to chronic hepatitis B infection. Cornea. 2017;36:515–7.

    Article  Google Scholar 

  42. Aiello F, Congliaro P, Malaspina C, Gallo Afflitto G, Nucci C. Peripheral ulcerative keratitis as the primary clinical manifestation of type 2 cryoglobulinemia. Can J Ophthalmol. 2021;56:e148–50.

    Article  Google Scholar 

  43. Saygin D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol. 2018;5:165–8.

    Article  Google Scholar 

  44. Chawla B, Agarwal P, Tandon R, Titiyal JS. Peripheral ulcerative keratitis with bilateral optic nerve involvement as an initial presentation of acute lymphocytic leukemia in an adult. Int Ophthalmol. 2009;29:53–5.

    Article  Google Scholar 

  45. Morjaria R, Barge T, Mordant D, Elston J. Peripheral ulcerative keratitis as a complication of acute myeloid leukaemia. BMJ Case Rep. 2014; 2014.

  46. Lim LT, Ramamurthi S, Collins CE, Mantry S. Peripheral ulcerative keratitis associated with multiple myeloma. Ann Acad Med Singap. 2011;40:550–1.

    Google Scholar 

  47. Prasher P, Di Pascuale M, Cavanagh HD. Bilateral chronic peripheral ulcerative keratitis secondary to cat-scratch disease. Eye Contact Lens. 2008;34:191–3.

    Article  Google Scholar 

  48. Lange AP, Moloney G, Sheldon CA, Sasaki S, Holland SP. Bilateral corneal ulceration caused by vitamin a deficiency in eosinophilic gastroenteropathy. Case Rep Ophthalmol. 2011;2:302–6.

    Article  Google Scholar 

  49. Ramanathan S, Fraser C, Curnow SR, Ghaly M, Leventer RJ, Lechner-Scott J, Henderson A, Reddel S, Dale RC, Brilot F. Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity. Eur J Neurol. 2019;26:1137-e1175.

    Article  CAS  Google Scholar 

  50. Vosoughi AR, Ling J, Tam KT, Blackwood J, Micieli JA. Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review. Br J Ophthalmol. 2021;105:1591–8.

    Article  Google Scholar 

  51. Siracuse-Lee D, Saffra N. Peripheral ulcerative keratitis in sarcoidosis: a case report. Cornea. 2006;25:618–20.

    Article  Google Scholar 

  52. Harthan JS, Reeder RE. Peripheral ulcerative keratitis in association with sarcoidosis. Cont Lens Anterior Eye. 2013;36:313–7.

    Article  Google Scholar 

  53. Cordoba A, Mejia LF, Gonzalez N, Gil JC. Unusual corneal sarcoidosis manifestations. Ocul Immunol Inflamm. 2022; 1–5.

  54. Mehta K, Gujjar AP, Babu K. Peripheral ulcerative keratitis in a young lady with systemic lupus erythematosus post rituximab infusion—a case report. Ocul Immunol Inflamm. 2022; 1–3.

  55. Cohen F, Gabison EE, Stephan S, Belkhir R, Nocturne G, Best AL, Haigh O, Barreau E, Labetoulle M, Seror R, et al. Peripheral ulcerative keratitis in rheumatoid arthritis patients taking tocilizumab: paradoxical manifestation or insufficient efficacy? Rheumatology (Oxford). 2021;60:5413–8.

    Article  CAS  Google Scholar 

  56. Far PM, Quinn MP, Johnson D. Bilateral peripheral ulcerative keratitis associated with Dupilumab. Ophthalmology. 2022;129:561.

    Article  Google Scholar 

  57. Penbe A. Peripheral ulcerative keratitis secondary to the inactive COVID-19 vaccine-CoronaVac. Ocul Immunol Inflamm. 2022; 1–5.

  58. Parker JS, Feagin W, Wang C, Heersink M, Parker JS. Corneal ulceration associated with Nivolumab use. Am J Ophthalmol Case Rep. 2019;14:26–7.

    Article  Google Scholar 

  59. Antoun J, Titah C, Cochereau I. Ocular and orbital side-effects of checkpoint inhibitors: a review article. Curr Opin Oncol. 2016;28:288–94.

    Article  CAS  Google Scholar 

  60. Kusumesh R, Ambasta A, Arya LK, Mohan N, Sinha BP, Ravidas V. Keratitis occurring in patients treated with miltefosine for post-kala-azar dermal leishmaniasis. Br J Ophthalmol. 2021;105:1497–503.

    Article  Google Scholar 

  61. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124:1678–89.

    Article  Google Scholar 

  62. Brown SI, Mondino BJ. Therapy of Mooren’s ulcer. Am J Ophthalmol. 1984;98:1–6.

    Article  CAS  Google Scholar 

  63. Sangwan VS, Zafirakis P, Foster CS. Mooren’s ulcer: current concepts in management. Indian J Ophthalmol. 1997;45:7–17.

    CAS  Google Scholar 

  64. Ashar JN, Mathur A, Sangwan VS. Immunosuppression for Mooren’s ulcer: evaluation of the stepladder approach–topical, oral and intravenous immunosuppressive agents. Br J Ophthalmol. 2013;97:1391–4.

    Article  Google Scholar 

  65. Pleyer U, Bertelmann E, Rieck P, Hartmann C. Outcome of penetrating keratoplasty in rheumatoid arthritis. Ophthalmologica. 2002;216:249–55.

    Article  CAS  Google Scholar 

  66. Ngan ND, Chau HT. Amniotic membrane transplantation for Mooren’s ulcer. Clin Exp Ophthalmol. 2011;39:386–92.

    Article  Google Scholar 

  67. Chen KH, Hsu WM, Liang CK. Relapsing Mooren’s ulcer after amniotic membrane transplantation combined with conjunctival autografting. Ophthalmology. 2004;111:792–5.

    Article  Google Scholar 

  68. Schallenberg M, Westekemper H, Steuhl KP, Meller D. Amniotic membrane transplantation ineffective as additional therapy in patients with aggressive Mooren’s ulcer. BMC Ophthalmol. 2013;13:81.

    Article  Google Scholar 

  69. Eiferman RA, Carothers DJ, Yankeelov JA Jr. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol. 1979;87:703–9.

    Article  CAS  Google Scholar 

  70. Genvert G, Sakauye CM, Arentsen JJ. Treatment of marginal corneal ulcers with cryotherapy and conjunctival recession or resection. Cornea. 1984;3:256–61.

    Article  Google Scholar 

  71. Feder RS, Krachmer JH. Conjunctival resection for the treatment of the rheumatoid corneal ulceration. Ophthalmology. 1984;91:111–5.

    Article  CAS  Google Scholar 

  72. Lal I, Shivanagari SB, Ali MH, Vazirani J. Efficacy of conjunctival resection with cyanoacrylate glue application in preventing recurrences of Mooren’s ulcer. Br J Ophthalmol. 2016;100:971–5.

    Article  Google Scholar 

  73. Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology. Ophthalmology. 2020;127:128–33.

    Article  Google Scholar 

  74. Mavrakanas NA, Kiel R, Dosso AA. Autologous serum application in the treatment of Mooren’s ulcer. Klin Monbl Augenheilkd. 2007;224:300–2.

    Article  CAS  Google Scholar 

  75. Katz EA, Sunshine S, Mun C, Sarwar M, Surenkhuu B, Pradeep A, Jain S. Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (“Triple Play”) in Recalcitrant Immunological Ocular Surface Diseases. Ocul Surf. 2022;23:1–11.

    Article  Google Scholar 

  76. Chen J, Lan J, Liu D, Backman LJ, Zhang W, Zhou Q, Danielson P. Ascorbic acid promotes the stemness of corneal epithelial stem/progenitor cells and accelerates epithelial wound healing in the cornea. Stem Cells Transl Med. 2017;6:1356–65.

    Article  CAS  Google Scholar 

  77. Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond). 1995;9(Pt 6):703–18.

    Article  Google Scholar 

  78. Smith VA, Hoh HB, Easty DL. Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol. 1999;83:1376–83.

    Article  CAS  Google Scholar 

  79. Bordin P. Low-Concentration (0.66%) Povidone Iodine treatment of a corneal ulcer in a rheumatoid arthritis patient. Am J Case Rep. 2021;22:e928748.

    Article  Google Scholar 

  80. Saripalli L, Harrington TM, Notz RG, Torretti D. Corneal melt in rheumatic disorders: effect of disease-modifying antirheumatic drugs on morbidity. J Clin Rheumatol. 2005;11:134–9.

    Article  Google Scholar 

  81. Petrushkin HJ, Stanford M, Fortune F, Jawad A. Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:S18-19.

    Google Scholar 

  82. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984;91:1253–63.

    Article  CAS  Google Scholar 

  83. Ogra S, Sims JL, McGhee CNJ, Niederer RL. Ocular complications and mortality in peripheral ulcerative keratitis and necrotising scleritis: the role of systemic immunosuppression. Clin Exp Ophthalmol. 2020;48:434–41.

    Article  Google Scholar 

  84. Stylianides A, Jones MN, Stewart RM, Murphy CC, Goodson NJ, Kaye SB. Rheumatoid arthritis-associated corneal ulceration: mortality and graft survival. Ophthalmology. 2013;120:682–6.

    Article  Google Scholar 

  85. Bernauer W, Ficker LA, Watson PG, Dart JK. The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes. Ophthalmology. 1995;102:1325–37.

    Article  CAS  Google Scholar 

  86. Dominguez-Casas LC, Sanchez-Bilbao L, Calvo-Rio V, Maiz O, Blanco A, Beltran E, Martinez-Costa L, Demetrio-Pablo R, Del Buergo MA, Rubio-Romero E, et al. Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. Semin Arthritis Rheum. 2020;50:608–15.

    Article  CAS  Google Scholar 

  87. Ebrahimiadib N, Modjtahedi BS, Roohipoor R, Anesi SD, Foster CS. successful treatment strategies in granulomatosis with polyangiitis-associated peripheral ulcerative keratitis. Cornea. 2016;35:1459–65.

    Article  Google Scholar 

  88. Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, Seror R, Marotte H, Mariette X, Nocturne G. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. RMD Open. 2021; 7.

  89. Guindolet D, Reynaud C, Clavel G, Belange G, Benmahmed M, Doan S, Hayem G, Cochereau I, Gabison EE. Management of severe and refractory Mooren’s ulcers with rituximab. Br J Ophthalmol. 2017;101:418–22.

    Article  Google Scholar 

  90. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–32.

    Article  CAS  Google Scholar 

  91. Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371:1771–80.

    Article  Google Scholar 

  92. Lohchab M, Prakash G, Arora T, Maharana P, Jhanji V, Sharma N, Vajpayee RB. Surgical management of peripheral corneal thinning disorders. Surv Ophthalmol. 2019;64:67–78.

    Article  Google Scholar 

  93. Skeens HM, Holland EJ. Large-diameter penetrating keratoplasty: indications and outcomes. Cornea. 2010;29:296–301.

    Article  Google Scholar 

  94. Reinprayoon U, Srihatrai P, Satitpitakul V, Puangsricharern V, Wungcharoen T, Kasetsuwan N. Survival outcome and prognostic factors of corneal transplantation: a 15-year retrospective cohort study at King Chulalongkorn Memorial Hospital. Clin Ophthalmol. 2021;15:4189–99.

    Article  Google Scholar 

  95. Raizman MB. Sainz de la Maza M, Foster CS: Tectonic keratoplasty for peripheral ulcerative keratitis. Cornea. 1991;10:312–6.

    Article  CAS  Google Scholar 

  96. Bessant DA, Dart JK. Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation. Eye (Lond). 1994;8(Pt 1):22–8.

    Article  Google Scholar 

  97. Yokoyama K, Nakamura R, Otsuka T, Kimoto K, Kubota T. Deep anterior lamellar keratoplasty and peripheral lamellar keratoplasty for a case of severe peripheral ulcerative keratitis. Case Rep Ophthalmol. 2022;13:9–16.

    Article  Google Scholar 

  98. Trese M, Schimmel O, Gupta C. Extensive autoimmune keratolysis with subsequent corneal perforation managed with tectonic endothelial keratoplasty. Am J Ophthalmol Case Rep. 2021;21:101031.

    Article  Google Scholar 

  99. Roberts HW, Gunasekera CD, Law EM, Seifelnasr M, Giannaccare G, Busin M, Myerscough J. Sutureless tectonic mini-Descemet’s stripping automated endothelial keratoplasty (“mini-DSAEK”) for the management of corneal perforations. Eur J Ophthalmol. 2022;32:2133–40.

    Article  Google Scholar 

  100. Kaushal S, Jhanji V, Sharma N, Tandon R, Titiyal JS, Vajpayee RB. “Tuck in” lamellar keratoplasty (TILK) for corneal ectasias involving corneal periphery. Br J Ophthalmol. 2008;92:286–90.

    Article  CAS  Google Scholar 

  101. Rodriguez-Ares MT, Tourino R, Lopez-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea. 2004;23:577–83.

    Article  Google Scholar 

  102. Chen Y, Zhang L, Liu Z, Liu Q, Gao M. Efficacy of lamellar keratoplasty with acellular porcine corneal stroma in treatment for infectious central and peripheral corneal ulcers. Ther Clin Risk Manag. 2021;17:623–34.

    Article  CAS  Google Scholar 

  103. Solomon A, Meller D, Prabhasawat P, John T, Espana EM, Steuhl KP, Tseng SC. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109:694–703.

    Article  Google Scholar 

  104. Yildiz EH, Nurozler AB, Ozkan Aksoy N, Altiparmak UE, Onat M, Karaguzel H. Amniotic membrane transplantation: indications and results. Eur J Ophthalmol. 2008;18:685–90.

    Article  CAS  Google Scholar 

  105. Anitha V, Ghorpade A, Ravindran M. A modified Tenons sling annular graft for advanced peripheral ulcerative keratitis with an hourglass cornea. Indian J Ophthalmol. 2022;70:655–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Duke University, Durham, NC, 27705, USA

    Amol A. Sura

  2. C.S. Foster Center for Ocular Immunology, Duke University, Durham, NC, USA

    Amol A. Sura

Authors
  1. Amol A. Sura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amol A. Sura.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

No human or animal studies were associated with preparation of this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Cornea

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sura, A.A. Peripheral Ulcerative Keratitis: Management. Curr Ophthalmol Rep 10, 99–106 (2022). https://doi.org/10.1007/s40135-022-00301-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-022-00301-8

Keywords

Search

Navigation